André Bento‐Abreu

1.1k total citations
18 papers, 833 citations indexed

About

André Bento‐Abreu is a scholar working on Neurology, Genetics and Epidemiology. According to data from OpenAlex, André Bento‐Abreu has authored 18 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in André Bento‐Abreu's work include Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Vaccine Coverage and Hesitancy (4 papers). André Bento‐Abreu is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Vaccine Coverage and Hesitancy (4 papers). André Bento‐Abreu collaborates with scholars based in Belgium, United States and Spain. André Bento‐Abreu's co-authors include Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht, Nicole Hersmus, Arantxa Tabernero, José M. Medina, Kim A. Staats, Mieke Timmers, William D. Richardson and Thomas Philips and has published in prestigious journals such as Neuron, Brain and Journal of Neurochemistry.

In The Last Decade

André Bento‐Abreu

16 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Bento‐Abreu Belgium 12 383 372 231 171 144 18 833
Javier H. Jara United States 14 249 0.7× 434 1.2× 271 1.2× 175 1.0× 140 1.0× 15 677
Lucía Galán Spain 14 442 1.2× 285 0.8× 153 0.7× 103 0.6× 52 0.4× 41 789
Virginia Le Verche United States 8 274 0.7× 248 0.7× 154 0.7× 111 0.6× 124 0.9× 9 562
Mito Shiote Japan 14 216 0.6× 412 1.1× 276 1.2× 198 1.2× 86 0.6× 21 643
Hisae Sumi Japan 11 311 0.8× 289 0.8× 118 0.5× 142 0.8× 159 1.1× 15 707
Martine Therrien Canada 12 355 0.9× 318 0.9× 223 1.0× 184 1.1× 99 0.7× 17 808
Anissa Fergani France 10 271 0.7× 635 1.7× 373 1.6× 157 0.9× 85 0.6× 10 843
Kaori Kawai Japan 17 532 1.4× 441 1.2× 245 1.1× 106 0.6× 114 0.8× 27 980
Stefania Battistini Italy 18 411 1.1× 543 1.5× 299 1.3× 127 0.7× 139 1.0× 51 1.0k
Kerstin E. Braunstein United States 13 275 0.7× 267 0.7× 159 0.7× 97 0.6× 100 0.7× 13 581

Countries citing papers authored by André Bento‐Abreu

Since Specialization
Citations

This map shows the geographic impact of André Bento‐Abreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Bento‐Abreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Bento‐Abreu more than expected).

Fields of papers citing papers by André Bento‐Abreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Bento‐Abreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Bento‐Abreu. The network helps show where André Bento‐Abreu may publish in the future.

Co-authorship network of co-authors of André Bento‐Abreu

This figure shows the co-authorship network connecting the top 25 collaborators of André Bento‐Abreu. A scholar is included among the top collaborators of André Bento‐Abreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Bento‐Abreu. André Bento‐Abreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bento‐Abreu, André, et al.. (2025). The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium. Oncology and Therapy. 13(3). 735–753.
2.
Bento‐Abreu, André, et al.. (2024). Fiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework. Expert Review of Pharmacoeconomics & Outcomes Research. 24(3). 437–445. 1 indexed citations
3.
Carrico, Justin, Sandra E. Talbird, André Bento‐Abreu, et al.. (2023). Public health impact and return on investment of Belgium’s pediatric immunization program. Frontiers in Public Health. 11. 1032385–1032385. 6 indexed citations
4.
Benčina, Goran, et al.. (2022). Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study. Expert Review of Vaccines. 22(1). 148–160. 3 indexed citations
5.
Rossaert, Elisabeth, Sandra Duqué, Laura Rué, et al.. (2021). AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS. Molecular Therapy — Methods & Clinical Development. 20. 508–519. 16 indexed citations
6.
Simoens, Steven, et al.. (2021). Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium. Frontiers in Pharmacology. 12. 628434–628434. 8 indexed citations
7.
Swinnen, Bart, André Bento‐Abreu, Tania F. Gendron, et al.. (2018). A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathologica. 135(3). 427–443. 88 indexed citations
8.
9.
Staats, Kim A., Stéphanie Humblet‐Baron, André Bento‐Abreu, et al.. (2016). Genetic ablation of IP3receptor 2 increases cytokines and decreases survival ofSOD1G93Amice. Human Molecular Genetics. 25(16). 3491–3499. 22 indexed citations
10.
Staats, Kim A., Lawrence Van Helleputte, Ashley Jones, et al.. (2013). Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice. Neurobiology of Disease. 60. 11–17. 14 indexed citations
11.
Staats, Kim A., Susann Schönefeldt, André Bento‐Abreu, et al.. (2013). Rapamycin increases survival in ALS mice lacking mature lymphocytes. Molecular Neurodegeneration. 8(1). 31–31. 54 indexed citations
12.
Timmers, Mieke, Nicole Hersmus, André Bento‐Abreu, et al.. (2013). Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Human Molecular Genetics. 22(9). 1783–1790. 117 indexed citations
13.
Philips, Thomas, André Bento‐Abreu, Annelies Nonneman, et al.. (2013). Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 136(2). 471–482. 205 indexed citations
14.
Miśkiewicz, Katarzyna, André Bento‐Abreu, Jarosław Kasprowicz, et al.. (2011). ELP3 Controls Active Zone Morphology by Acetylating the ELKS Family Member Bruchpilot. Neuron. 72(5). 776–788. 84 indexed citations
15.
Bento‐Abreu, André, Philip Van Damme, Ludo Van Den Bosch, & Wim Robberecht. (2010). The neurobiology of amyotrophic lateral sclerosis. European Journal of Neuroscience. 31(12). 2247–2265. 65 indexed citations
16.
Bento‐Abreu, André, Ana Luisa Velasco, Concepción Lillo, et al.. (2009). Albumin endocytosis via megalin in astrocytes is caveola‐ and Dab‐1 dependent and is required for the synthesis of the neurotrophic factor oleic acid. Journal of Neurochemistry. 111(1). 49–60. 41 indexed citations
17.
Bento‐Abreu, André, et al.. (2008). Megalin is a receptor for albumin in astrocytes and is required for the synthesis of the neurotrophic factor oleic acid. Journal of Neurochemistry. 106(3). 1149–1159. 55 indexed citations
18.
Bento‐Abreu, André, Arantxa Tabernero, & José M. Medina. (2007). Peroxisome proliferator‐activated receptor‐alpha is required for the neurotrophic effect of oleic acid in neurons. Journal of Neurochemistry. 103(3). 871–881. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier H. Jara Breakdown of academic impact, for papers by Lucía Galán Breakdown of academic impact, for papers by Virginia Le Verche Breakdown of academic impact, for papers by Mito Shiote Breakdown of academic impact, for papers by Hisae Sumi Breakdown of academic impact, for papers by Martine Therrien Breakdown of academic impact, for papers by Anissa Fergani Breakdown of academic impact, for papers by Kaori Kawai Breakdown of academic impact, for papers by Stefania Battistini Breakdown of academic impact, for papers by Kerstin E. Braunstein
Rankless by CCL
2026